UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018140
Receipt number R000021000
Scientific Title Effectiveness and safety of bronchial thermoplasty in the treatment with severe persistent bronchial asthma
Date of disclosure of the study information 2015/06/30
Last modified on 2023/07/06 20:24:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effectiveness and safety of bronchial thermoplasty in the treatment with severe persistent bronchial asthma

Acronym

Effectiveness and safety of bronchial thermoplasty in patients with severe asthma

Scientific Title

Effectiveness and safety of bronchial thermoplasty in the treatment with severe persistent bronchial asthma

Scientific Title:Acronym

Effectiveness and safety of bronchial thermoplasty in patients with severe asthma

Region

Japan


Condition

Condition

Bronchial asthma

Classification by specialty

Pneumology Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma in Japanese patients.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Asthma exacerbation

Key secondary outcomes

Asthma control
Pulmonary function
QOL
Bronchial wall thickness, diameter
Adverse events


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Uncontrolled severe asthma patients treated with high dose inhaled corticosteroid and long acting beta 2 agonists
2.Eligible for fiberoptic bronchoscopy

Key exclusion criteria

1.Have a pacemaker, internal defibrillator, or other implantable electronic device.
2.Have a known sensitivity to medications required to perform bronchoscopy, including lidocaine, atropine, and benzodiazepines.
3.Have been previously treated with BT
4.Active respiratory infection
5.Asthma exacerbation or changing dose of systemic corticosteroids for asthma (up or down) in the past 14 days
6.Known coagulopathy. As with other bronchoscopic procedures, patients should stop taking anticoagulants, antiplatelet agents, aspirin, and NSAIDS before the procedure with physician guidance

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Motoyasu
Middle name
Last name Iikura

Organization

National Center for Global Health and Medicine

Division name

Respiratory Medicine

Zip code

162-8655

Address

Toyama 1-21-1, Shinjukuku, Tokyo, Japan

TEL

03-3202-7181

Email

iikura-tky@umin.ac.jp


Public contact

Name of contact person

1st name Motoyasu
Middle name
Last name Iikura

Organization

National Center for Global Health and Medicine

Division name

Respiratory Medicine

Zip code

162-8655

Address

Toyama 1-21-1, Shinjukuku, Tokyo, Japan

TEL

03-3202-7181

Homepage URL


Email

iikura-tky@umin.ac.jp


Sponsor or person

Institute

Department of Respiratory Medicine, National Center for Global Health and Medicine

Institute

Department

Personal name



Funding Source

Organization

National Center for Global Health and Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Certified Review Board of National Center for Global Health and Medicine

Address

Toyama 1-21-1, Shinjukuku, Tokyo, Japan

Tel

03-3202-7181

Email

kenkyu-shinsa@hosp.ncgm.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 30 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications

https://www.sciencedirect.com/science/article/pii/S1323893017301077?via%3Dihub

Number of participants that the trial has enrolled

30

Results

Asthma-related Quality of Life Questionnaire (AQLQ) and Asthma Control Questionnaire (ACQ)-5 scores were improved at both 1 and 12 months after BT. Mean FEV1 was increased at 1 and 12 months. The mean annual number of severe exacerbations requiring systemic corticosteroids decreased from 5.8 to 2.0 at 12 months after BT. No serious adverse event was observed.

Results date posted

2023 Year 07 Month 06 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2017 Year 07 Month 29 Day

Baseline Characteristics


Participant flow


Adverse events


Outcome measures

Improvement of Asthma-related Quality of Life Questionnaire (AQLQ) and Asthma Control Questionnaire (ACQ)-5 scores, %FEV1 and reduction of severe asthma exacerbation were obsereved at 12 months after BT.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 06 Month 15 Day

Date of IRB

2015 Year 06 Month 15 Day

Anticipated trial start date

2015 Year 06 Month 30 Day

Last follow-up date

2024 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective study


Management information

Registered date

2015 Year 06 Month 30 Day

Last modified on

2023 Year 07 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021000


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name